| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $67.23B | +13.7% |
| Cost of Revenue | $63.55B | +13.9% |
| Gross Profit | $3.68B | +9.5% |
| R&D Expense | $33.0M | +0.0% |
| SG&A Expense | $1.37B | +10.9% |
| Interest Expense | $403.0M | +65.8% |
| Pre-tax Income | $2.07B | -19.5% |
| Income Tax | $388.0M | -2.5% |
| Net Income | $1.61B | -22.5% |
| EPS (Basic) | $10.83 | -25.3% |
| EPS (Diluted) | $10.51 | -22.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | +22.4% |
| Short-term Investments | $119.0M | -77.1% |
| Accounts Receivable | $2.83B | +33.9% |
| Inventory | $8.41B | -0.3% |
| Current Assets | $16.76B | +1.8% |
| Total Assets | $24.58B | +3.2% |
| Current Liabilities | $9.60B | +3.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.55B | -91.7% |
| Capital Expenditures | $555.0M | +39.1% |
| Investing Cash Flow | $6.50B | +27.1% |
| Financing Cash Flow | -$769.0M | +52.9% |
| Free Cash Flow | -$6.10B | -85.4% |
| Long-term Debt |
| $4.11B |
| -22.4% |
| Stockholders' Equity | $9.22B | +20.3% |